MORGAN STANLEY PLC/CALL/CENTENE/100/0.1/20.12.24 Share Price

Warrant

DE000MB3P4C5

Real-time Bid/Ask 10:27:29 03/06/2024 pm IST
0.051 EUR / 0.059 EUR +10.00% Intraday chart for MORGAN STANLEY PLC/CALL/CENTENE/100/0.1/20.12.24
1 month-37.50%
3 months-80.00%
Date Price Change
03/24/03 0.048 -4.00%
31/24/31 0.05 +13.64%
30/24/30 0.044 -16.98%
29/24/29 0.053 -25.35%
28/24/28 0.071 +7.58%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 07:24 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CENTENE CORPORATION
Issuer Morgan Stanley
WKN MB3P4C
ISINDE000MB3P4C5
Date issued 15/02/2023
Strike 100 $
Maturity 20/12/2024 (200 Days)
Parity 10 : 1
Emission price 0.65
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.83
Lowest since issue 0.033
Delta0.09x
Omega 10.65
Premium42.42x
Gearing115.88x
Moneyness 0.7065
Difference Strike 29.18 $
Difference Strike %+29.18%
Spread 0.006
Spread %10.17%
Theoretical value 0.0560
Implied Volatility 29.74 %
Total Loss Probability 93.94 %
Intrinsic value 0.000000
Present value 0.0560
Break even 100.61 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.
Sector
-
More about the company

Ratings for Centene Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Centene Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
71.59 USD
Average target price
88.57 USD
Spread / Average Target
+23.72%
Consensus